These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1472149)

  • 1. Dose-dependent effects of recombinant human erythropoietin on the reticulocyte population of rabbits.
    Fuchs A; Eder H
    Arzneimittelforschung; 1992 Oct; 42(10):1266-8. PubMed ID: 1472149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modification of reticulocyte count and distribution of degree of maturity by erythropoietin in the rat].
    Eder H; Wiemer U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):517-22. PubMed ID: 2446992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dose-dependent effect of recombinant erythropoietin on the reticulocyte population of rats.
    Eder H; Rosslenbroich B; Failing K
    Blut; 1989 Aug; 59(2):184-7. PubMed ID: 2475191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Number and maturation distribution of the reticulocytes from six animal species].
    Fuchs A; Eder H
    Zentralbl Veterinarmed A; 1991 Dec; 38(10):749-54. PubMed ID: 1796677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects.
    Cheung WK; Goon BL; Guilfoyle MC; Wacholtz MC
    Clin Pharmacol Ther; 1998 Oct; 64(4):412-23. PubMed ID: 9797798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The quantification of reticulocyte maturation and neocytolysis in normal and erythropoietin stimulated rats.
    Wiczling P; Krzyzanski W; Zychlińska N; Lewandowski K; Kaliszan R
    Biopharm Drug Dispos; 2014 Sep; 35(6):330-40. PubMed ID: 24888906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic effects of recombinant human erythropoietin on the central nervous system after subarachnoid hemorrhage: reduction of microcirculatory impairment and functional deficits in a rabbit model.
    Murphy AM; Xenocostas A; Pakkiri P; Lee TY
    J Neurosurg; 2008 Dec; 109(6):1155-64. PubMed ID: 19035736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of recombinant human erythropoietin and interleukin-3 on erythropoietic recovery from acute anemia.
    Rosen BS; Levine EA; Egrie JC; Sehgal LR; Greenberg R; Rosen AL; Levine HD; Gould SA
    Exp Hematol; 1993 Oct; 21(11):1487-91. PubMed ID: 8405228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of biological activity and safety of recombinant canine erythropoietin with that of recombinant human erythropoietin in clinically normal dogs.
    Randolph JF; Stokol T; Scarlett JM; MacLeod JN
    Am J Vet Res; 1999 May; 60(5):636-42. PubMed ID: 10328437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulocyte maturity index reflects erythropoietin effects in hemodialysis patients.
    Han YS; Kishimoto T
    Osaka City Med J; 1997 Jun; 43(1):69-76. PubMed ID: 9343995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of fetal hemoglobin synthesis with recombinant human erythropoietin in anemic patients with heterozygous beta-thalassemia during pregnancy.
    Breymann C; Fibach E; Visca E; Huettner C; Huch A; Huch R
    J Matern Fetal Med; 1999; 8(1):1-7. PubMed ID: 10052837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of erythropoietin in vitro on rabbit reticulocyte membrane Ca2+-ATPase activity.
    Lawrence WD; Davis PJ; Blas SD
    J Clin Invest; 1987 Aug; 80(2):586-9. PubMed ID: 2956280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic analysis of recombinant human erythropoietin effect on reticulocyte production rate and age distribution in healthy subjects.
    Pérez-Ruixo JJ; Krzyzanski W; Hing J
    Clin Pharmacokinet; 2008; 47(6):399-415. PubMed ID: 18479174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reticulocyte changes after experimental anemia and erythropoietin treatment of horses.
    Cooper C; Sears W; Bienzle D
    J Appl Physiol (1985); 2005 Sep; 99(3):915-21. PubMed ID: 16103516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic studies following percutaneous absorption of erythropoietin micropiles to rats.
    Ito Y; Shiroyama K; Yoshimitsu J; Ohashi Y; Sugioka N; Takada K
    J Control Release; 2007 Aug; 121(3):176-80. PubMed ID: 17628163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of reticulocyte maturation after erythropoietin administration in rats.
    Wiczling P; Ait-Oudhia S; Krzyzanski W
    Cytometry A; 2009 Jul; 75(7):584-92. PubMed ID: 19437531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and erythropoietic response to human recombinant erythropoietin in healthy men.
    Flaharty KK; Caro J; Erslev A; Whalen JJ; Morris EM; Bjornsson TD; Vlasses PH
    Clin Pharmacol Ther; 1990 May; 47(5):557-64. PubMed ID: 2188770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antierythropoietin antibodies in thalassemia patients.
    Voulgari PV; Chaidos A; Tzouvara E; Alymara V; Alamanos Y; Drosos AA; Bourantas KL
    Ann Hematol; 2004 Jan; 83(1):22-7. PubMed ID: 14530877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics and haematological effects of erythropoietin in horses.
    Jaussaud P; Audran M; Gareau RL; Souillard A; Chavanet I
    Vet Res; 1994; 25(6):568-73. PubMed ID: 7889038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing autologous blood donation by recombinant human erythropoietin (rhu-EPO) and interleukin 3 (IL-3).
    Krieter H; Frey L; Segiet W; Brückner UB; Krumwieh D; Seiler FR; Messmer K
    Behring Inst Mitt; 1991 Dec; (90):75-85. PubMed ID: 1801694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.